The award validates what Resbiotic CEO and founder Dr. Vivek Lal, MD, has explained: that rigorous science, product-level clinical evidence and relentless execution can build category-defining health companies. “What makes this award especially meaningful is that it reflects years of work by an exceptional team, our scientific collaborators, healthcare partners, investors, retailers, and, most importantly, the thousands of customers who have trusted us with their health,” Lal said. In the last five years, customers have put their faith in products developed by Resbiotic and Lal’s early insights into the microbiome. Resbiotic now has 10 products, including a gut test created in partnership with Tiny Health, the first microbiome platform to address infant gut imbalances. As for the start-up award, Dr. Lal acknowledged the role science continues to play in his company’s success.